Marcello Maggiolini Selected Research

G-Protein-Coupled Receptors (Receptors, G Protein Coupled)

12/2018	GPCR Modulation in Breast Cancer.
12/2017	G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts.
6/2017	Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.
4/2016	Response to "Comment on 'Effects of Atrazine on Estrogen Receptor 〈- and G Protein-Coupled Receptor 30-Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts'".
3/2016	Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling.
1/2016	Macromolecular Modelling and Docking Simulations for the Discovery of Selective GPER Ligands.
10/2015	A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models.
5/2015	Effects of atrazine on estrogen receptor α- and G protein-coupled receptor 30-mediated signaling and proliferation in cancer cells and cancer-associated fibroblasts.
8/2014	GPER mediates activation of HIF1α/VEGF signaling by estrogens.
1/2014	GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcello Maggiolini Research Topics

Disease

86	Neoplasms (Cancer) 01/2022 - 07/2002
76	Breast Neoplasms (Breast Cancer) 06/2022 - 07/2002
10	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2011
9	Hypoxia (Hypoxemia) 01/2022 - 01/2011
8	Triple Negative Breast Neoplasms 06/2022 - 01/2014
6	Carcinogenesis 02/2021 - 05/2004
6	Prostatic Neoplasms (Prostate Cancer) 12/2017 - 11/2002
4	Ovarian Neoplasms (Ovarian Cancer) 05/2015 - 02/2007
3	Lung Neoplasms (Lung Cancer) 08/2016 - 03/2009
2	Carcinoma (Carcinomatosis) 07/2017 - 12/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2016 - 03/2009
2	Endometrial Neoplasms (Endometrial Cancer) 06/2012 - 03/2006
1	Peripheral Arterial Disease 01/2022
1	Hyperinsulinism (Hyperinsulinemia) 01/2022
1	Obesity 02/2021
1	Inflammation (Inflammations) 02/2021

Drug/Important Bio-Agent (IBA)

49	Estrogens (Estrogen)FDA Link 11/2021 - 07/2002
41	Estrogen ReceptorsIBA 01/2022 - 07/2002
28	GTP-Binding Proteins (G-Protein)IBA 08/2020 - 12/2012
25	Biological ProductsIBA 01/2022 - 07/2002
22	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2018 - 06/2004
15	Hormones (Hormone)IBA 01/2022 - 07/2002
14	Estrogen Receptor alphaIBA 01/2020 - 07/2002
12	LigandsIBA 04/2016 - 11/2002
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2004
9	Insulin-Like Growth Factor I (IGF-1)IBA 02/2021 - 08/2008
8	Insulin (Novolin)FDA Link 01/2022 - 10/2014
8	AndrogensIBA 12/2017 - 07/2002
7	Pharmaceutical PreparationsIBA 01/2022 - 01/2011
7	Aromatase (CYP19)IBA 05/2015 - 07/2002
6	ErbB Receptors (EGF Receptor)IBA 01/2022 - 02/2007
6	Tamoxifen FDA LinkGeneric 07/2014 - 03/2006
5	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 11/2002
5	Insulin ReceptorIBA 01/2022 - 01/2021
5	MicroRNAs (MicroRNA)IBA 03/2019 - 06/2015
5	SteroidsIBA 09/2013 - 11/2002
5	Epidermal Growth Factor (EGF)IBA 08/2010 - 08/2008
4	Growth Factor ReceptorsIBA 02/2019 - 12/2008
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017 - 01/2013
4	Transcription Factors (Transcription Factor)IBA 07/2017 - 03/2009
4	Estradiol (Delestrogen)FDA LinkGeneric 01/2011 - 07/2002
4	afimoxifene (hydroxytamoxifen)IBA 05/2010 - 03/2006
3	Focal Adhesion Protein-Tyrosine KinasesIBA 06/2022 - 02/2019
3	CytokinesIBA 11/2021 - 04/2016
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2014
3	IntegrinsIBA 02/2021 - 11/2010
3	Collagen ReceptorsIBA 01/2021 - 02/2016
3	Peptides (Polypeptides)IBA 01/2020 - 06/2017
3	EnzymesIBA 12/2017 - 07/2002
3	Fatty Acids (Saturated Fatty Acids)IBA 08/2017 - 11/2011
3	IGF Type 1 Receptor (IGF 1 Receptor)IBA 08/2016 - 09/2009
3	AtrazineIBA 04/2016 - 12/2008
3	Oxygen (Dioxygen)IBA 03/2016 - 03/2011
3	Connective Tissue Growth FactorIBA 01/2013 - 03/2009
3	Messenger RNA (mRNA)IBA 08/2010 - 05/2004
3	GenisteinIBA 10/2006 - 11/2002
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 04/2014
2	Protein Isoforms (Isoforms)IBA 11/2021 - 01/2021
2	ChemokinesIBA 11/2021 - 06/2017
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 04/2021 - 01/2019
2	Discoidin Domain Receptor 1IBA 01/2021 - 02/2016
2	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2021 - 01/2017
2	ResveratrolIBA 10/2020 - 07/2009
2	Furylfuramide (AF2)IBA 01/2020 - 01/2019
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2019 - 02/2016
2	Aromatase InhibitorsIBA 12/2018 - 07/2002
2	LipidsIBA 01/2018 - 11/2011
2	Hypoxia-Inducible Factor 1IBA 12/2017 - 01/2013
2	CopperIBA 12/2017 - 10/2015
2	Trace Elements (Biometals)IBA 12/2017 - 01/2017
2	ZincIBA 12/2017 - 01/2017
2	Doxycycline (Periostat)FDA LinkGeneric 09/2017 - 08/2017
2	Vasoconstrictor AgentsIBA 02/2016 - 03/2009
2	PesticidesIBA 05/2015 - 12/2008
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 04/2014 - 09/2009
2	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 03/2014 - 06/2010
2	oleuropeinIBA 03/2014 - 06/2010
2	titanoceneIBA 01/2014 - 06/2013
2	Caveolin 1IBA 11/2013 - 07/2012
2	bisphenol AIBA 08/2012 - 12/2003
2	ElementsIBA 09/2010 - 02/2007
2	Estrogen Receptor betaIBA 12/2008 - 06/2004
2	QuercetinIBA 06/2004 - 11/2002
2	Phytoestrogens (Phytoestrogen)IBA 06/2004 - 11/2002
2	Steroid Receptors (Steroid Receptor)IBA 06/2004 - 12/2003
1	FilaminsIBA 06/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Interleukin-11 (Interleukin 11)IBA 11/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2021
1	Receptor for Advanced Glycation End ProductsIBA 02/2021
1	AlarminsIBA 02/2021
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 10/2020
1	Tyrosine Kinase InhibitorsIBA 10/2020
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2020
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 10/2020
1	Insulin-Like PeptidesIBA 01/2020

Therapy/Procedure

13	Therapeutics 01/2022 - 06/2013
1	Immunotherapy 01/2022